REPLIGEN CORP (RGEN)

SEC filing

REPLIGEN CORP

RGEN · CIK 730272

4 · Oct 6, 2026 · Director, Chief Executive Officer Loeillot Olivier sold 5,535 shares at $187.29/share ($1.0M); exercised options for 8,404 shares

Director, Chief Executive Officer Loeillot Olivier sold 5,535 shares at $187.29/share ($1.0M); exercised options for 8,404 shares

FORM 4

xslF345X06/wk-form4_1791317904.xmlSEC.gov

Graphics and non-inline formats (not embedded below).